Publication: 364

Publication: 364

N0539 Phase II Trial of Fulvstrant and Bevacizumab in Patients with Metastatic Breast Cancer Previously Treated with an Aromatase Inhibitor: A North Central Cancer Treatment Group Trial.

URL

Google Scholar

Citation:: Cancer Res vol 69 (24 suppl 3) abstr 738S

Meeting Instance:: SABCS 2009
Year:: 2009
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 1036 2149

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: W. W. Tan A. C. Dueck P. Flynn P. Steen D. Anderson K. Rowland Jr D. Nothfeldt W. Lingle J. Copland E. A. Perez

Networks:

Study: NCCTG-N0539
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: